103 related articles for article (PubMed ID: 7692876)
1. Characterisation of human tumour cell lines using antibodies to intermediate filaments.
Moorthi C; Willers I; Ressler B; Goedde HW
Pathobiology; 1993; 61(3-4):197-9. PubMed ID: 7692876
[TBL] [Abstract][Full Text] [Related]
2. Modulation of expression of intermediate filaments during the development of established rat liver cell lines.
Langbein L; Neupert G
Acta Histochem; 1986; 80(2):149-58. PubMed ID: 2433884
[TBL] [Abstract][Full Text] [Related]
3. Absence of cytokeratin in human hepatoma cell lines.
Lo SJ; Yang CW; Hu CP; Chang CM
Cell Biol Int Rep; 1987 Jun; 11(6):477-86. PubMed ID: 2441881
[TBL] [Abstract][Full Text] [Related]
4. A patient with lepromatous leprosy and anticytoskeletal antibodies.
Frey FL; Gottlieb AB; Levis WR
J Am Acad Dermatol; 1988 May; 18(5 Pt 2):1179-84. PubMed ID: 2453540
[TBL] [Abstract][Full Text] [Related]
5. Anticytoskeletal autoantibody development in adjuvant arthritis.
Franch A; Castellote C; Vilà JL; Vilaró S; Castell M
J Rheumatol; 1994 Mar; 21(3):489-97. PubMed ID: 7516431
[TBL] [Abstract][Full Text] [Related]
6. Co-expression of cytokeratin and vimentin intermediate-sized filaments in renal cell carcinomas. Comparative study of the intermediate-sized filament distribution in renal cell carcinomas and normal human kidney.
Waldherr R; Schwechheimer K
Virchows Arch A Pathol Anat Histopathol; 1985; 408(1):15-27. PubMed ID: 2414900
[TBL] [Abstract][Full Text] [Related]
7. Fluorescence study of renal cell carcinoma with antibodies to renal tubular antigens, intermediate filaments, and lectins.
Iizumi T; Yazaki T; Kanoh S; Koiso K; Koyama A; Tojo S
Urol Int; 1986; 41(1):57-61. PubMed ID: 2421471
[TBL] [Abstract][Full Text] [Related]
8. Vimentin filaments follow the preexisting cytokeratin network during epithelial-mesenchymal transition of cultured neonatal rat hepatocytes.
Pagan R; Martín I; Alonso A; Llobera M; Vilaró S
Exp Cell Res; 1996 Feb; 222(2):333-44. PubMed ID: 8598222
[TBL] [Abstract][Full Text] [Related]
9. [Changes of intermediate filament during mitosis in two epithelial cell lines].
Cai ST
Shi Yan Sheng Wu Xue Bao; 1990 Dec; 23(4):465-75. PubMed ID: 1705741
[TBL] [Abstract][Full Text] [Related]
10. Microinjection of monoclonal antibodies specific for one intermediate filament protein in cells containing multiple keratins allow insight into the composition of particular 10 nm filaments.
Tölle HG; Weber K; Osborn M
Eur J Cell Biol; 1985 Sep; 38(2):234-44. PubMed ID: 2412818
[TBL] [Abstract][Full Text] [Related]
11. Antibodies to intermediate filaments in surgical pathology.
Lehto VP; Miettinen M; Virtanen I
Arch Geschwulstforsch; 1986; 56(4):283-98. PubMed ID: 2428329
[TBL] [Abstract][Full Text] [Related]
12. [Antibodies against intermediate filaments--a contribution to the differential diagnosis of salivary gland tumors].
Caselitz J; Wustrow J; Osborn M
Laryngol Rhinol Otol (Stuttg); 1986 Jul; 65(7):384-8. PubMed ID: 2427905
[TBL] [Abstract][Full Text] [Related]
13. [Immunohistochemical analysis of 42 renal cell carcinomas and one oncocytoma with mono- and polyclonal antibodies against vimentin and cytokeratin].
Beham A; Ratschek M; Zatloukal K; Denk H; Lackinger E
Verh Dtsch Ges Pathol; 1989; 73():392-5. PubMed ID: 2482624
[TBL] [Abstract][Full Text] [Related]
14. Epithelial tumor markers: cytokeratins and tissue polypeptide antigen (TPA).
Moll R
Curr Top Pathol; 1987; 77():71-101. PubMed ID: 2448088
[No Abstract] [Full Text] [Related]
15. Cytolocation of prosome antigens on intermediate filament subnetworks of cytokeratin, vimentin and desmin type.
Olink-Coux M; Arcangeletti C; Pinardi F; Minisini R; Huesca M; Chezzi C; Scherrer K
J Cell Sci; 1994 Mar; 107 ( Pt 3)():353-66. PubMed ID: 7516340
[TBL] [Abstract][Full Text] [Related]
16. Aggregation of a subpopulation of vimentin filaments in cultured human skin fibroblasts derived from patients with giant axonal neuropathy.
Bousquet O; Basseville M; Vila-Porcile E; Billette de Villemeur T; Hauw JJ; Landrieu P; Portier MM
Cell Motil Cytoskeleton; 1996; 33(2):115-29. PubMed ID: 8635201
[TBL] [Abstract][Full Text] [Related]
17. Alteration in composition of keratin intermediate filaments in a model of breast cancer progression and the potential to reverse hallmarks of metastasis.
Mackinder MA; Evans CA; Chowdry J; Staton CA; Corfe BM
Cancer Biomark; 2012; 12(2):49-64. PubMed ID: 23396250
[TBL] [Abstract][Full Text] [Related]
18. Changing patterns of cytokeratins and vimentin in the early chick embryo.
Page M
Development; 1989 Jan; 105(1):97-107. PubMed ID: 2478357
[TBL] [Abstract][Full Text] [Related]
19. Identification of cytoskeletal structures in hormone producing lung cancer cell cultures.
Broers JL; Gropp C; Bepler G; Rot MK; Beck J; Schaart G; Vooijs GP; Ramaekers FC
Acta Histochem Suppl; 1987; 34():57-75. PubMed ID: 2437618
[TBL] [Abstract][Full Text] [Related]
20. Intermediate filament reactivity in hyperplastic and neoplastic lesions from medaka (Oryzias latipes).
Bunton TE
Exp Toxicol Pathol; 1994 Oct; 46(4-5):389-96. PubMed ID: 7534529
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
